Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 101-111 , 2009

Urinary tract infections caused by Pseudomonas aeruginosa: A minireview

  • Rahul Mittal

      Affiliations

    • Division of Infectious Diseases, Childrens Hospital Los Angeles, Los Angeles, CA, USA
    • Department of Microbiology, Panjab University, Chandigarh, India
    • Corresponding Author InformationCorresponding author at: Division of Infectious Diseases, MS#51, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, USA. Tel.: +1 323 361 5809.
    • ,
  • Sudhir Aggarwal

      Affiliations

    • Department of Physiology, University of Tennessee Health Sciences Center, Memphis, TN, USA
    • ,
  • Saroj Sharma

      Affiliations

    • Department of Microbiology, Panjab University, Chandigarh, India
    • ,
  • Sanjay Chhibber

      Affiliations

    • Department of Microbiology, Panjab University, Chandigarh, India
    • ,
  • Kusum Harjai

      Affiliations

    • Department of Microbiology, Panjab University, Chandigarh, India

Received 1 July 2009 ,Revised 12 August 2009 ,Accepted 13 August 2009.

References 

  1. Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin North Am. 2006;53:379–400
  2. Kucheria R, Dasgupta P, Sacks SH, Khan MS, Sheerin NS. Urinary tract infections: new insights into a common problem. Postgrad Med J. 2005;81:83–86
  3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49:53–70
  4. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328–1334
  5. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, et al. Urologic Diseases in America Project: analytical methods and principal findings. J Urol. 2005;173:933–937
  6. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992;29:19–24
  7. Kunin C. Detection, prevention and management of urinary tract infections. Philadelphia: Lea and Febiger; 1987;
  8. Williams DH, Schaeffer AJ. Current concepts in urinary tract infections. Minerva Urol Nefrol. 2004;56:15–31
  9. Mittal R, Chhibber S, Sharma S, Harjai K. Macrophage inflammatory protein-2, neutrophil recruitment and bacterial persistence in an experimental mouse model of urinary tract infection. Microbes Infect. 2004;6:1326–1332
  10. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35:1–12
  11. Bonadio M, Meini M, Gigli C, Longo B, Vigna A. Urinary tract infection in diabetic patients. Urol Int. 1999;63:215–219
  12. Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoepelman AIM. Adherence of type I-fimbriated Escherichia coli to uroepithelial cells. Diabetes Care. 2002;25:1405–1409
  13. Leone M, Albanese J, Garnier F, Sapin C, Barrau K, Bimar MC, et al. Risk factors of nosocomial catheter-associated urinary tract infection in a polyvalent intensive care unit. Int Care Med. 2003;29:929–932
  14. Munoz JA, Perez-Esteban B, Esteban M, de la Escalera S, Gomez MA, Martinez-Toledo MV, et al. Growth of moderately halophilic bacteria isolated from sea water using phenol as the sole carbon source. Folia Microbiol (Praha). 2001;46:297–302
  15. Read RR, Eberwein P, Dasgupta MK, Grant SK, Lam K, Nickel JC, et al. Peritonitis in peritoneal dialysis: Bacterial colonization by biofilm spread along the catheter. Kid Int. 1988;35:614–621
  16. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146:719–723
  17. Bass PF, Jarvis JA, Mitchell CK. Urinary tract infections. Prim Care. 2003;30:41–61
  18. Reid G. Current scientific understanding of urinary tract infections in women: an overview. World J Urol. 1999;17:336–338
  19. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am. 2003;17:411–432
  20. Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, et al. Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol. 2005;162:1207–1214
  21. Kalsi J, Arya M, Wilson P, Mundy A. Hospital-acquired urinary tract infection. Int J Clin Pract. 2003;57:388–391
  22. Logan K. Indwelling catheters: developing an integrated care pathway package. Nurs Times. 2003;99:49–51
  23. Dickinson GM, Bisno AL. Infections associated with indwelling devices: infections related to extravascular device. Antimicrob Agents Chemother. 1989;33:602–607
  24. Chang SC, Chen YC, Hsu LY. Epidemiologic study of pathogens causing nosocomial infections. J Formos Med Assoc. 1990;89:1023–1030
  25. Fluit AC, Schmitz FJ, Verhoef J. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis. 2001;20:188–191
  26. Hootan TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17:259–268
  27. Johnson JR, Berggren T, Manivel JC. Histopathologic–microbiologic correlates of invasiveness in a mouse model of ascending unobstructed urinary tract infection. J Infect Dis. 1992;165:299–305
  28. Matheson NR, Potempa J, Travis J. Interaction of a novel form of Pseudomonas aeruginosa alkaline protease (aeruginolysin) with interleukin-6 and interleukin-8. Biol Chem. 2006;387:911–915
  29. Yates SP, Jorgensen R, Andersen GR, Merrill AR. Stealth and mimicry by deadly bacterial toxins. Trends Biochem. 2006;31:123–133
  30. Zulianello L, Canard C, Kohler T, Caille D, Lacroix JS, Meda P. Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect Immun. 2006;74:3134–3147
  31. Veesenmeyer JL, Hauser AR, Lisboa T, Rello J. Pseudomonas aeruginosa virulence and therapy: evolving translational strategies. Crit Care Med. 2009;37:1777–1786
  32. Lysczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000;2:1051–1060
  33. Smith DC, Spooner RA, Watson PD, Murray JL, Hodge TW, Amessou M, et al. Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic. 2006;7:379–393
  34. Vance RE, Rietsch A, Mekalanos JJ. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun. 2005;73:1706–1713
  35. Woods DE, Lam JS, Parenchych W, Speet DP, Campbell M, Godfrey AJ. Correlation of virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse model. Can J Microbiol. 1997;43:541–551
  36. Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol. 1986;24:260–264
  37. Hamood AN, Griswold JA, Duhan CM. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J Surg Res. 1996;61:425–432
  38. Ciragil P, Soyletir G. Alginate elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites. Mikrobiyol Bull. 2004;38:341–347
  39. Visca P, Chiarini F, Mansi A, Vetriani C, Serino L, Orsi N. Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections. Epidemiol Infect. 1992;108:323–336
  40. Mittal R, Khandwaha RK, Gupta V, Mittal PK, Harjai K. Phenotypic characters of urinary isolates of Pseudomonas aeruginosa and their association with mouse renal colonization. Indian J Med Res. 2006;123:67–72
  41. Hoiby N, Johnsen HK, Moser C, Song Z, Ciofu O, Kharazmi A. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Micro Infect. 2001;3:23–35
  42. Klausen M, Aaes-Jorgensen A, Molin S, Tolker-Nielsen T. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol. 2003;50:61–68
  43. Kuchma SL, Connoly JP, O’Toole GA. A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J Bacteriol. 2005;187:1441–1454
  44. Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol. 2007;10:644–648
  45. Friedman L, Kolter R. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aerguinosa biofilm matrix. J Bacteriol. 2004;186:4457–4465
  46. Jackson KD, Starkey M, Kremer S, Parsek MR, Wozniak DJ. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol. 2004;186:4466–4475
  47. Ma LY, Jackson K, Landry RM, Parsek MR, Wozniak DJ. Analysis of Pseudomonas aeruginosa conditional Psl variants reveals roles for the Psl polysaccharide in adhesion and maintaining biofilm structure postattachment. J Bacteriol. 2006;188:8213–8221
  48. Ma L, Lu H, Sprinkle A, Parsek MR, Wozniak DJ. Pseudomonas aeruginosa Psl is a galactose- and mannose-rich exopolysaccharide. J Bacteriol. 2007;189:8353–8356
  49. Campisano A, Schroeder C, Schemionek M, Overhage J, Rehm BHA. PslD is a secreted protein required for biofilm formation by Pseudomonas aeruginosa. Appl Environ Microbiol. 2006;72:3066–3068
  50. Overhage J, Schemionek M, Webb JS, Rehm BHA. Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm formation. Appl Environ Microbiol. 2005;71:4407–4413
  51. Vasseur P, Vallet-Gely I, Soscia C, Genin S, Filloux A. The pel genes of the Pseudomonas aeruginosa PAK strain are involved at early and late stages of biofilm formation. Microbiology. 2005;151:985–997
  52. Boles BR, Thoendel M, Singh PK. Self-generated diversity produces “insurance effects” in biofilm communities. Proc Natl Acad Sci USA. 2004;101:16630–16635
  53. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001;33:1387–1392
  54. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect. 2003;5:1213–1239
  55. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193
  56. Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 2005;13:7–10
  57. Trautner BW, Darouiche RO. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med. 2004;164:842–850
  58. Stamm AM, Coutinho MS. Urinary tract infection associated with indwelling bladder catheter incidence and risk factors. Rev Assoc Med Brass. 1999;45:27–33
  59. Trautner BW, Hull RA, Darouiche RO. Prevention of catheter-associated urinary tract infection. Curr Opin Infect Dis. 2005;18:37–41
  60. Beltran J, Pericas R, Lopez VL, Virto BJL, Prats PG, Verger GG. Urinary infection in patients with short-term bladder catheterization. Med Clin. 1991;96:161–164
  61. Parsons CL. Pathogenesis of urinary tract infections: bacterial adherence, bladder defense mechanisms. Urol Din North Am. 1986;13:563–568
  62. Bissett L. Reducing the risk of catheter-related urinary tract infection. Nurs Times. 2005;101:64–65
  63. Bonadio M, Pichierri G, Costarelli S, Morelli G, Tanzilli P, Tartaglia T, et al. Catheter-associated urinary tract infections (CAUTI): distribution of uropathogens and patterns of antimicrobial resistance in an Italian hospital (1996–2003). J Chemother. 2005;17:560–562
  64. Niel-Weise BS, van den Broek PJ. Antibiotic policies for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev. 2005;3:CD005428
  65. Locci R, Peters G, Pulverer G. Microbiol colonization of prosthetic devices. I. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Microbiol Hyg Abt Orig. 1981;173:285–289
  66. Peters G, Locci R, Pulverer G. Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Microbiol Hyg Abt Orig. 1982;173:293–296
  67. Costerton JW, Irvin RT, Cheng KJ. The bacterial glycocalyx in nature and disease. Ann Rev Microbiol. 1981;35:299–324
  68. Nickel JC, Grant SK, Costerton JW. Catheter-associated bacteriuria. An experimental study. Urology. 1985;26:369–375
  69. Ganderton L, Chawla J, Winters C, Wimpenny J, Stickler D. Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. Eur J Clin Microbiol Infect Dis. 1992;11:789–796
  70. Stickler DJ, Morris NS, McLean RJ, Fuqua C. Biofilms on indwelling uretheral catheters produce quorum sensing signal molecules in situ and in vitro. Appl Environ Microbiol. 1998;64:3486–3490
  71. Kurosaka Y, Ishida Y, Yamamura E, Takase H, Otani T, Kumon H. A non-surgical rat model of foreign body-associated urinary tract infection with Pseudomonas aeruginosa. Microbiol Immunol. 2001;45:9–15
  72. Webb JS, Lau M, Kjelleberg S. Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. J Bacteriol. 2004;186:8066–8073
  73. Rice SA, Tan CH, Mikkelsen PJ, Kung V, Woo J, Tay M, et al. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME J. 2009;3:271–282
  74. Mittal R, Sharma S, Chhibber S, Harjai K. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis. Microb Pathog. 2008;45:323–330
  75. Gambello MJ, Iglewski BH. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol. 1991;173:3000–3009
  76. Ochsner UA, Reiser J. Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 1995;92:6424–6428
  77. Pearson JP, Gray KM, Passador L, Tucker KD, Eberhard A, Iglewski BH, et al. Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci USA. 1994;91:197–201
  78. Pearson JP, Passador L, Iglewski BH, Greenberg EP. A second N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 1995;92:1490–1494
  79. Winson MK, Camara M, Latifi A, Foglino M, Chhabra SR, Daykin M, et al. Multiple N-acyl-l-homoserine lactone signal molecules regulate production of virulence determinants and secondary metabolites in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 1995;92:9427–9431
  80. Seed PC, Passador L, Iglewski BH. Activation of the Pseudomonas aeruginosa lasI gene by LasR and the Pseudomonas autoinducer PAI: an autoinduction regulatory hierarchy. J Bacteriol. 1995;177:654–659
  81. Passador L, Cook JM, Gambello MJ, Rust L, Iglewski BH. Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication. Science. 1993;260:1127–1130
  82. Pearson JP, Pesci EC, Iglewski BH. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol. 1997;179:5756–5767
  83. Gambello MJ, Kaye S, Iglewski BH. LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression. Infect Immun. 1993;61:1180–1184
  84. Chapon-Herve V, Akrim M, Latifi A, Williams P, Lazdunski A, Bally M. Regulation of the xcp secretion pathway by multiple quorum sensing modulons in Pseudomonas aeruginosa. Mol Microbiol. 1997;24:1169–1178
  85. Latifi A, Foglino M, Tanaka K, Williams P, Lazdunski A. A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhIR (VsmR) to expression of the stationary-phase sigma factor RpoS. Mol Microbiol. 1996;21:1137–1146
  86. Pesci EC, Pearson JP, Seed PC, Iglewski BH. Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol. 1997;179:3127–3132
  87. Brint JM, Ohman DE. Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J Bacteriol. 1995;177:7155–7163
  88. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280:295–298
  89. Lesprit P, Faurisson F, Join-Lambert O, Roudot-Thoraval F, Foglino M, Vissuzaine C, et al. Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. Am J Respir Crit Care Med. 2003;167:1478–1482
  90. Pearson JP, Feldman M, Iglewski BH, Prince A. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun. 2000;68:4331–4334
  91. Rumbaugh KP, Griswold JA, Hamood AN. Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: variations in virulence factors and virulence genes. J Hosp Infect. 1999;43:211–218
  92. Wu H, Song Z, Givskov M, Doring G, Worlitzsch D, Mathee K, et al. Pseudomonas aeruginosa mutations in lasI and rhlI quorum sensing systems result in milder chronic lung infection. Microbiology. 2001;147:1105–1113
  93. Zhu H, Bandara R, Conibear TC, Thuruthyil SJ, Rice SA, Kjelleberg S, et al. Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. Invest Ophthalmol Vis Sci. 2004;45:1897–1903
  94. Parker CT, Sperandio V. Cell-to-cell signalling during pathogenesis. Cell Microbiol. 2009;11:363–369
  95. Mittal R, Sharma S, Chhibber S, Harjai K. Contribution of quorum-sensing systems to virulence of Pseudomonas aeruginosa in an experimental pyelonephritis model. J Microbiol Immunol Infect. 2006;39:302–309
  96. Haussler S, Becker T. The Pseudomonas quinolone signal (PQS) balances life and death in Pseudomonas aeruginosa populations. PLoS Pathog. 2008;4:e1000166
  97. Farrow JM, Sund ZM, Ellison ML, Wade DS, Coleman JP, Pesci EC. PqsE functions independently of PqsR-Pseudomonas quinolone signal and enhances the rhl quorum-sensing system. J Bacteriol. 2008;190:7043–7051
  98. Dubern JF, Diggle SP. Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol Biosyst. 2008;4:882–888
  99. Kim EJ, Sabra W, Zeng AP. Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology. 2003;149:2627–2634
  100. Shand GH, Anwar H, Kadurugamuwa J, Brown M, Silvermann SH, Melling J. In vivo evidence that bacteria in urinary tract infection grow under iron restricted conditions. Infect Immun. 1985;48:35–39
  101. Suh SJ, Suh SL, Woods DE, Hassett DJ, West SEH, Ohman DE. Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol. 1999;181:3890–3897
  102. Lamont IL, Beare PA, Ochsner U, Vasil AI, Vasil ML. Siderophore mediated signaling regulates virulence factor production in Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 2002;99:7072–7077
  103. Sriyosachati S, Cox CD. Siderophore mediated iron acquisition from transferrin by Pseudomonas aeruginosa. Infect Immun. 1986;52:885–891
  104. Winzer K, Falconer C, Garber NC, Diggle SP, Camara M, Williams P. The Pseudomonas aeruginosa lectins PA-IL and PA-IIL are controlled by quorum sensing and by RpoS. J Bacteriol. 2000;182:6401–6411
  105. Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Iron and infection: the heart of the matter. FEMS Immunol Med Microbiol. 2005;43:325–330
  106. Bjorn MJ, Iglewski BH, Ives SK, Sadoff JC, Vasil ML. Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA-103. Infect Immun. 1978;19:785–791
  107. Bjorn MJ, Sokol PA, Iglewski BH. Influence of iron on yields of extracellular products in Pseudomonas aeruginosa cultures. J Bacteriol. 1979;138:193–200
  108. Woods DE, Iglewski BH, Johanson WG. Host and bacterial factors in the colonization of the respiratory tract. In:  Schlessinger D editors. Microbiology. Washington, D.C.: American Society for Microbiology; 1982;p. 348–352
  109. Sokol PA, Woods DE. Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections. J Med Microbiol. 1984;18:125–133
  110. Mittal R, Sharma S, Chhibber S, Harjai K. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J Biomed Sci. 2008;15:731–741
  111. Mittal R, Sharma S, Chhibber S, Harjai K. Effect of osmolarity on virulence of uropathogenic Pseudomonas aeruginosa. Am J Biomed Sci. 2009;1:12–26
  112. Culham DE, Dalgado C, Gyles CL, Mamelak D, MacLellan S, Wood JW. Osmoregulatory transporter ProP influences colonization of the urinary tract by Escherichia coli. Microbiology. 1998;144:91–102
  113. Kokot F, Dulawa J. Tamm–Horsfall protein updated. Nephron. 2000;85:97–102
  114. Seraffini-cesssi F, Malagolini N, Cavallone D. Tamm–Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis. 2003;42:658–676
  115. Duncan JL. Differential effect of Tamm–Horsfall protein on adherence of Escherichia coli to transitional epithelial cells. J Infec Dis. 1988;158:1379–1389
  116. Mittal R, Sharma S, Chhibber S, Harjai K. Alteration in virulence characteristics of biofilm cells of Pseudomonas aeruginosa in presence of Tamm–Horsfall Protein. World J Microbiol Biotechnol. 2006;22:915–919
  117. Harjai K, Mittal R, Chhibber S, Sharma S. Contribution of Tamm–Horsfall protein to virulence of Pseudomonas aeruginosa in urinary tract infection. Microbes Infect. 2005;7:132–137
  118. Hawthorn LA, Bruce AW, Reid G. Ability of uropathogens to bind to Tamm–Horsfall protein coated renal tubular cells. Urol Res. 1991;1:301–304
  119. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319–326
  120. Mittal R, Sharma S, Chhibber S, Harjai K. Effect of macrophage secretory products on elaboration of virulence factors by planktonic and biofilm cells of Pseudomonas aeruginosa. Comp Immunol Microbiol Infect Dis. 2006;29:12–26
  121. Haraoka M, Hang L, Frendeus B, Godaly G, Burdick M, Strieter R, et al. Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis. 1999;180:1220–1229
  122. Jung H, Eckmann L, Yang S, Panja A, Fierer J, Wroblewska E, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995;95:55–65
  123. Godaly G, Bergsten G, Hang L, Fischer H, Frendeus B, Lundstedt AC, et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol. 2001;69:899–906
  124. Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, Karpman D, et al. Uropathogenic Escherichia coli as a model of host–parasite interaction. Curr Opin Microbiol. 2006;9:33–39
  125. Agace WW, Hedges SR, Ceska M, Svanborg C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest. 1993;92:780–785
  126. Hedges S, Linder H, de Man P, Svanborg Eden C. Ciclosporin-dependent, nu-independent, mucosal interleukin 6 response to gram-negative bacteria. Scand J Immunol. 1990;31:335–343
  127. Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, et al. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989;142:144–147
  128. Lopponow H, Libby P, Freudenberg M, Krauss J, Weckesser J, Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun. 1990;58:3743–3750
  129. Godaly G, Bergsten G, Frendeus B, Hang L, Hedlund M, Karpman D, et al. Innate defences and resistance to gram negative mucosal infection. Adv Exp Med Biol. 2000;485:9–24
  130. Olszyna DP, Vermeulen H, Baan AH, Speelman P, van Deventer SJ, Gouma DJ, et al. Urine interleukin-8 is a marker for urinary tract infection in postoperative patients. Infection. 2001;29:274–277
  131. Kassir K, Vargas-Shiraishi O, Zaldivar F, Berman M, Singh J, Arrieta A. Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact. Clin Diagn Lab Immunol. 2001;8:1060–1063

PII: S1876-0341(09)00058-6

doi: 10.1016/j.jiph.2009.08.003

Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 101-111 , 2009

Article Tools

* Image Usage & Resolution